Skip to content

Taste-masking Study for Tricaprilin in Sensory Panelists

An Open-Label Taste Assessment of Tricaprilin Formulated as a Powder for Reconstitution in Healthy Panelists

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03628352
Acronym
TMS
Enrollment
9
Registered
2018-08-14
Start date
2018-09-10
Completion date
2019-08-22
Last updated
2019-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Taste Profile Assessments

Brief summary

This is an open-label multiple-dose study of the taste profile of tricaprilin formulated as a powder for reconstitution.

Interventions

Tricaprilin with flavoring agents added

Sponsors

Cerecin
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. The healthy male or female sensory panelist is between 25 and 80 years of age (inclusive) who volunteers for study participation and is able to read, understand, and sign and date a written informed consent form (ICF) before study participation. 2. The panelist is male, or is a non-pregnant, non-lactating female who agrees to comply with any applicable contraceptive requirements of the protocol, or is a female of non-childbearing potential. 3. The sensory panelist is qualified based on training and experience. 4. The panelist is able to perform the required procedures according to the specified methodology 5. The panelist has provided full written consent to participate in the study.

Exclusion criteria

1. The sensory panelist has a history of any illness that, in the opinion of the investigator, might confound the results of the study or pose an additional risk in administering study drug(s) to the sensory panelist. 2. The sensory panelist has a known sensitivity to medium-chain triglycerides (MCTs) or any of the excipients used in study formulations. 3. The sensory panelist has a known history of kidney disease, inflammatory bowel disease, or Bradycardia. . 4. If female, the sensory panelist is pregnant, nursing, planning to become pregnant during the study. 5. Panelist must not have any planned hospitalizations or in-patient surgical procedures that are scheduled to take place during the study.

Design outcomes

Primary

MeasureTime frameDescription
Taste as assessed by trained sensory panelists1 daysingle dose (swish and expectorate)
Smell as assessed by trained sensory panelists1 day
Texture as assessed by trained sensory panelists1 daysingle dose (swish and expectorate)
Palatability as assessed by trained sensory panelists1 daysingle dose (swish and expectorate)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026